Press Office

Following the First Consultative Forum on the mRNA Vaccines Technology Transfer Hub that took place on 9 December 2021.We would like to share with you the recording of the meeting on YouTube and a short video on the hub that was filmed last month in South Africa.

Forbes Africa – South African Startup’s mRNA Vaccine From Early Next Year. A Cape Town-based biotech startup has become the first African company to produce an mRNA vaccine on the continent, paving the way for the future of locally-manufactured vaccines. READ MORE

MPP signed a grant agreement with Afrigen Biologics (Pty) Ltd to establish a technology transfer hub. READ MORE

Finally some good news on the #vaccine front for the undeveloped and developing world. #southafrican company Afrigen Biologics (Pty) Ltd has made its own #mrna #covidvaccine. This will certainly mean more options/alternatives and better #access. Meanwhile more positive news also came the makers of Corbevax (which is going to manufactured in #india) that it is being offered patent-free. READ MORE

16 September 2021 | Lenias Hwenda | Let’s Talk about Health in Africa | Titans of Industry Episode 3 | Afrigen, a biotech with a passion for product formulation | Professor Petro Terblanche Afrigen is has got to be one of the most exciting biotech companies emerging out of Africa. Afrigen is a young company with a lot going on. The biotech is already supplying some of its products to Europeans and North American markets and it recently invested millions into building a clean room facility wand is now leading a WHO supported initiative to rapidly develop mRNA vaccines that meet PICS regulatory standards, the first of its kind on the African continent. Afrigen has a bright future ahead and it is ready to engage in significant business to business engagement with potential partners and investors. VIEW VIDEO

21 September 2021 | Lenias Hwenda | Let’s Talk about Health in Africa | Titans of Industry Episode 4 | Afrigen is now ready for significant business-business partnership | Prof. Petro Terblanche, Managing Director Afrigen Biologics and Vaccines Description Afrigen is one of the most exciting biotechnology companies coming out of Africa which already has a significant footprint in the market for adjuvants and delivery systems formulations. In this conversation Professor Terblanche explains that African has been operating quietly for some years developing and formulating products but this biotech is now ready to begin engaging with investors and other partners who can speed up its growth. VIEW VIDEO

23 September 20201 | Lenias Hwenda | Let’s Talk about Health in Africa | Titans of Industry Episode 5 | Afrigen seeking tech partners with scale, process, QA & QC experience | Petro Terblanche Description The Managing Director of Afrigen biologicals and vaccines, Professor Petro Terblanche explains Afrigen a unique Africa biotech company with unique attributes and the significance of Afrigen being the only biotech with adjuvant formulation capability outside Europe and the US. Few companies outside big Pharma in Europe and the US can formulate adjuvants. VIEW VIDEO

Afrigen gears up to deliver Africa’s first COVID-19 mRNA vaccine (Financial Post) VIEW HERE

Afrigen gears up to deliver Africa’s first COVID-19 mRNA vaccine (REUTERS.COM) VIEW HERE

Tedros says Afrigen Biologics and Vaccines and Biovac to be involved in MRNA transfer Hub in South Africa. READ MORE

MINISTER NZIMANDE WELCOMES WHO ANNOUNCEMENT ON SOUTH AFRICA’S FIRST HUB FOR mRNA VACCINES NEW TECHNOLOGY TRANSFER PROGRAMME. READ MORE

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.